Invesco Ltd. Bristol Myers Squibb CO Transaction History

Invesco Ltd.

$600 Billion
Q3 2025

A detailed history of Invesco Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Invesco Ltd. holds 17,626,080 shares of BMY stock, worth $825 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

17,626,080

Previous 18,315,473 3.76%

Holding current value

$825 Million

Previous $848 Million 6.24%

% of portfolio

0.13%

Previous 0.15%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$43.31 - $48.98 $29.9 Million - $33.8 Million	-689,393 Reduced 3.76%	17,626,080 $795 Million
Q2 2025 Aug 13, 2025	BUY	$44.12 - $59.6 $37.6 Million - $50.8 Million	852,317 Added 4.88%	18,315,473 $848 Million
Q1 2025 May 12, 2025	BUY	$53.9 - $63.11 $55.3 Million - $64.7 Million	1,025,766 Added 6.24%	17,463,156 $1.07 Billion
Q4 2024 Feb 13, 2025	BUY	$51.92 - $59.94 $12.6 Million - $14.5 Million	242,186 Added 1.5%	16,437,390 $930 Million
Q3 2024 Nov 12, 2024	BUY	$39.66 - $51.75 $62 Million - $80.9 Million	1,563,627 Added 10.69%	16,195,204 $838 Million

Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $89.5 Million - $118 Million	-2,223,481 Reduced 13.19%	14,631,577 $608 Million
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $60.1 Million - $68.2 Million	1,253,027 Added 8.03%	16,855,058 $914 Million
Q4 2023 Feb 12, 2024	SELL	$48.48 - $57.85 $220,874 - $263,564	-4,556 Reduced 0.03%	15,602,031 $801 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $71.8 Million - $80.3 Million	1,240,902 Added 8.64%	15,606,587 $906 Million
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $23.6 Million - $26.2 Million	-369,668 Reduced 2.51%	14,365,685 $919 Million
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $18.9 Million - $21.5 Million	-288,046 Reduced 1.92%	14,735,353 $1.02 Billion
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $255 Million - $302 Million	-3,723,858 Reduced 19.86%	15,023,399 $1.08 Billion
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $165,163 - $97.6 Million	1,270,485 Added 7.27%	18,747,257 $1.33 Billion
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $42 Million - $46.3 Million	578,586 Added 3.42%	17,476,772 $1.35 Billion
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $23.9 Million - $28.7 Million	-388,706 Reduced 2.25%	16,898,186 $1.23 Billion
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $83.4 Million - $97.3 Million	1,555,800 Added 9.89%	17,286,892 $1.08 Billion
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $19.6 Million - $23 Million	331,205 Added 2.15%	15,731,092 $931 Million
Q2 2021 Aug 17, 2021	SELL	$61.91 - $67.42 $99.6 Million - $108 Million	-1,608,299 Reduced 9.46%	15,399,887 $1.03 Billion
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $99.5 Million - $112 Million	-1,677,125 Reduced 8.98%	17,008,186 $1.07 Billion
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $146 Million - $165 Million	-2,522,611 Reduced 11.89%	18,685,311 $1.16 Billion
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $99.8 Million - $111 Million	-1,736,908 Reduced 7.57%	21,207,922 $1.28 Billion
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $17.8 Million - $20.8 Million	324,520 Added 1.43%	22,944,830 $1.35 Billion
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $123 Million - $178 Million	-2,642,278 Reduced 10.46%	22,620,310 $1.26 Billion
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $17.1 Million - $22.3 Million	346,940 Added 1.39%	25,262,588 $1.62 Billion
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $38.6 Million - $45.8 Million	902,962 Added 3.76%	24,915,648 $1.26 Billion
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $309 Million - $341 Million	6,915,526 Added 40.45%	24,012,686 $1.09 Billion
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $19.9 Million - $23.7 Million	440,868 Added 2.65%	17,097,160 $816 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $812 Million - $1.05 Billion	16,656,292 New	16,656,292 $866 Million

Others Institutions Holding BMY

# of Institutions

2,680

Shares Held

1.58B

Call Options Held

28M

Put Options Held

28.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account